CELLZOME
CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs for the treatment of inflammatory diseases. It develops a pipeline of kinase inhibitors targeting inflammatory mediators as oral therapeutics for rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis, and asthma. CellZome was founded in 2000 and is based in Heidelberg, Baden-Wurttemberg.
CELLZOME
Social Links:
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Heidelberg, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.cellzome.com
Total Employee:
51+
Status:
Closed
Contact:
+499193153362
Total Funding:
69.29 M USD
Technology used in webpage:
CSC Global DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) investment in Grant - CellZome
Atlas Venture
Atlas Venture investment in Series C - CellZome
Biofrontier Partners
Biofrontier Partners investment in Series C - CellZome
Schroder Ventures
Schroder Ventures investment in Series C - CellZome
Advent International
Advent International investment in Series C - CellZome
Societe Generale Asset Management
Societe Generale Asset Management investment in Series C - CellZome
Atlas Venture
Atlas Venture investment in Series B - CellZome
Advent International
Advent International investment in Series B - CellZome
Schroders
Schroders investment in Series B - CellZome
Index Ventures
Index Ventures investment in Series B - CellZome
Official Site Inspections
http://www.cellzome.com
- Host name: ns1.cellzome.de
- IP address: 195.37.234.227
- Location: Friedberg Germany
- Latitude: 50.3374
- Longitude: 8.7559
- Timezone: Europe/Berlin
- Postal: 61169
